UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems

European journal of pharmaceutical sciences, 2012-03, Vol.45 (4), p.482-491

2012

Link zum Volltext

Verfügbarkeit prüfen

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons

Immunity (Cambridge, Mass.), 2016-03, Vol.44 (3), p.597-608

2016

Link zum Volltext

Verfügbarkeit prüfen

Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells

The Journal of immunology (1950), 2013-06, Vol.190 (12), p.6311-6319

2013

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-Induced Th17 Cells Are Maintained Long-Term Postvaccination as a Distinct and Phenotypically Stable Memory Subset

Infection and Immunity, 2012-10, Vol.80 (10), p.3533-3544

2012

Link zum Volltext

Verfügbarkeit prüfen

Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate

The Journal of immunology (1950), 2010-03, Vol.184 (6), p.2756-2760

2010

Link zum Volltext

Verfügbarkeit prüfen

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen

Journal of controlled release, 2010-03, Vol.142 (2), p.180-186

2010

Link zum Volltext

Verfügbarkeit prüfen

The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling

PloS one, 2013-01, Vol.8 (1), p.e53531-e53531

2013

Link zum Volltext

Verfügbarkeit prüfen

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements

PloS one, 2008-09, Vol.3 (9), p.e3116-e3116

2008

Link zum Volltext

Verfügbarkeit prüfen

ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination

PloS one, 2013-12, Vol.8 (12), p.e80579-e80579

2013

Link zum Volltext

Verfügbarkeit prüfen

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

Journal of controlled release, 2010-07, Vol.145 (2), p.102-108

2010

Link zum Volltext

Verfügbarkeit prüfen

Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01

PloS one, 2014-06, Vol.9 (6), p.e100879-e100879

2014

Link zum Volltext

Verfügbarkeit prüfen

Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis

PloS one, 2016-08, Vol.11 (8), p.e0161217-e0161217

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses

Biochimica et biophysica acta, 2005-12, Vol.1718 (1), p.22-31

2005

Link zum Volltext

Verfügbarkeit prüfen

Dendritic Cells Prevent Rather Than Promote Immunity Conferred by a Helicobacter Vaccine Using a Mycobacterial Adjuvant

Gastroenterology (New York, N.Y. 1943), 2011-07, Vol.141 (1), p.186-196.e1

2011

Link zum Volltext

Verfügbarkeit prüfen

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis

Frontiers in immunology, 2018-01, Vol.8, p.1973-1973

2018

Link zum Volltext

Verfügbarkeit prüfen

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells

PloS one, 2009-06, Vol.4 (6), p.e5771-e5771

2009

Link zum Volltext

Verfügbarkeit prüfen

adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

Immunology, 2007-06, Vol.121 (2), p.216-226

2007

Link zum Volltext

Verfügbarkeit prüfen

T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties

EBioMedicine, 2018-01, Vol.27 (C), p.27-39

2018

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics

Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (3), p.1096-1101

2014

Link zum Volltext

Verfügbarkeit prüfen

The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders

PloS one, 2017-06, Vol.12 (6), p.e0177906-e0177906

2017

Link zum Volltext

Verfügbarkeit prüfen

Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses

The Journal of immunology (1950), 2012-05, Vol.188 (10), p.4828-4837

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates

Advanced drug delivery reviews, 2016-07, Vol.102, p.73-82

Agger, Else Marie

2016

Link zum Volltext

Verfügbarkeit prüfen

A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A0201 transgenic mice

PloS one, 2009-09, Vol.4 (9), p.e6950-e6950

2009

Link zum Volltext

Verfügbarkeit prüfen

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

Vaccine, 2005-04, Vol.23 (21), p.2740-2750

2005

Link zum Volltext

Verfügbarkeit prüfen

Liposome-based cationic adjuvant formulations (CAF): Past, present, and future

Journal of liposome research, , Vol.19 (1), p.2-11

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(108)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Animals
(70)
Life Sciences & Biomedicine
(64)
Immunology
(53)
Mice
(53)
Female
(42)
Mice, Inbred C57bl
(36)
Vaccines
(34)
Humans
(31)
Mycobacterium Tuberculosis
(30)
Tuberculosis
(29)
Antigens, Bacterial - Immunology
(25)
Infectious Diseases
(25)
Tuberculosis Vaccines - Immunology
(25)
Antigens
(24)
Biological And Medical Sciences
(24)
Mycobacterium Tuberculosis - Immunology
(23)
Adjuvants, Immunologic - Administration & Dosage
(22)
Vaccination
(22)
Adjuvant
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons

Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells

Vaccine-Induced Th17 Cells Are Maintained Long-Term Postvaccination as a Distinct and Phenotypically Stable Memory Subset

Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen

The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements

ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response

Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01

Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses

Dendritic Cells Prevent Rather Than Promote Immunity Conferred by a Helicobacter Vaccine Using a Mycobacterial Adjuvant

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells

adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties

Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics

The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders

Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses

Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates

A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A0201 transgenic mice

Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6

Liposome-based cationic adjuvant formulations (CAF): Past, present, and future

Suchergebnisse filtern